Quick Answer
Incannex Healthcare Inc. reported Cash and Equivalents of $15.04 million for fiscal year 2025.
Incannex Healthcare Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $15.04M | +156.7% |
| 2024 | $5.86M | -73.5% |
| 2023 | $22.12M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $68.90M | +3184.1% | -6.0% |
| September 30, 2025 | $73.28M | +1920.4% | +387.3% |
| June 30, 2025 | $15.04M | +156.7% | +124.1% |
| March 31, 2025 | $6.71M | -27.9% | +219.9% |
| December 31, 2024 | $2.10M | -85.6% | -42.2% |
| September 30, 2024 | $3.63M | — | -38.1% |
| June 30, 2024 | $5.86M | -73.5% | -37.0% |
| March 31, 2024 | $9.30M | — | -36.1% |
- Incannex Healthcare Inc. showed an increase of +156.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Incannex Healthcare Inc.’s cash and equivalents has declined by 32.0% (from $22.12 million to $15.04 million).
- The most recent figure is from Incannex Healthcare Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: